Your browser doesn't support javascript.
loading
Engineering prostate cancer in vitro: what does it take?
Buskin, Adriana; Scott, Emma; Nelson, Ryan; Gaughan, Luke; Robson, Craig N; Heer, Rakesh; Hepburn, Anastasia C.
Afiliación
  • Buskin A; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Scott E; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Nelson R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Gaughan L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Robson CN; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK. rakesh.heer@newcastle.ac.uk.
  • Hepburn AC; Faculty of Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, W12 0NN, UK. rakesh.heer@newcastle.ac.uk.
Oncogene ; 42(32): 2417-2427, 2023 08.
Article en En | MEDLINE | ID: mdl-37438470

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article